What is the CVSS score of CVE-2022-38351?

CVE-2022-38351 has a CVSS 3.1 base score of 8.8 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.9%.

Is there a public PoC exploit available for CVE-2022-38351?

Yes, a public proof-of-concept exploit is available for CVE-2022-38351. Prioritise patching immediately. EPSS: 0.9%.

Biostar 2 CVE-2022-38351

HIGH

Improper Privilege Management (CWE-269)

2022-09-19 cve@mitre.org

Privilege Escalation Biostar 2

8.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Sep 19, 2022 - 21:15 nvd

HIGH 8.8

DescriptionNVD

A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.

AnalysisAI

A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Improper Privilege Management (CWE-269), which allows attackers to escalate privileges to gain unauthorized elevated access. A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page. Affected products include: Supremainc Biostar 2.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply principle of least privilege, validate privilege transitions, implement proper role separation.